Related Experiment Video
Updated: Aug 9, 2026
05:14
Standardized Data Acquisition for Neuromelanin-Sensitive Magnetic Resonance Imaging of the Substantia Nigra
Published on: September 8, 2021
Substance abuse in patients with schizophrenia
Bernadette Winklbaur1, Nina Ebner, Gabriele Sachs
1Department of Psychiatry, Medical University of Vienna, Währinger Gürtel 18-20, 1090 Vienna, Austria.
Dialogues in Clinical Neuroscience
|April 28, 2006
Summary
Schizophrenia and substance abuse often co-occur, impacting treatment and outcomes. New therapeutic strategies are needed to address this complex comorbidity for better patient care.
Area of Science:
- Psychiatry
- Neuroscience
- Addiction Medicine
Background:
- Schizophrenia and substance abuse comorbidity is increasingly recognized.
- Potential links include genetic, neurobiological, medication side effects, and psychosocial factors.
- High prevalence of substance abuse in schizophrenia highlights the disorders' interdependence.
Purpose of the Study:
- To discuss the interaction and interdependence between schizophrenia and substance abuse.
- To explore potential new therapeutic avenues for patients with comorbid conditions.
- To emphasize the need for specialized treatment approaches.
Main Methods:
- Literature review and synthesis of existing research.
- Discussion of neurobiological and psychosocial factors.
- Analysis of treatment outcomes and challenges.
Main Results:
- Substance use, particularly heavy cannabis use, can trigger relapse in schizophrenia.
- Comorbidity is associated with poorer outcomes, including increased psychotic symptoms and reduced treatment compliance.
- Existing treatments may be insufficient for this complex patient population.
Conclusions:
- Effective care requires tailored treatment strategies for comorbid schizophrenia and substance abuse.
- Further research into the intricate relationship between these disorders is essential.
- Developing novel therapeutic paths is crucial for improving patient outcomes.
Related Concept Videos
01:28Drug Therapy
The advent of drug therapy has profoundly shaped modern mental health care, providing targeted treatments for a range of psychological disorders. Psychotherapeutic drugs, classified into antianxiety, antidepressant, and antipsychotic medications, address symptoms across anxiety disorders, mood disorders, and schizophrenia. While these medications have transformed patient outcomes, they require careful management due to their potential side effects and limitations.
Antianxiety Medications
Antianxiety Medications
01:28Psychosis and Antipsychotic Drugs: Overview
The term "psychosis" refers to a spectrum of mental disorders characterized by abnormal thoughts, perceptions, and behaviors. It can manifest as mood disorders, dementia, delirium with psychotic features, substance-induced psychosis with psychotic features, brief psychotic disorder, delusional disorder, schizoaffective disorder, and schizophrenia. Among all these disorders, schizophrenia is the most common psychotic disorder, affecting 1% of the worldwide population. Psychotic symptoms in all...
01:24Substance Use Disorders Affecting Sleep
Substance use disorders involve a pattern of using drugs more extensively than intended and continuing use despite harmful consequences. This includes legal substances like alcohol and nicotine, as well as illegal drugs. These disorders often involve both physical and psychological dependence, reflecting compulsive use of substances that significantly alter thoughts, feelings, and behaviors, contributing to a major public health issue.
Understanding the concepts of physical dependence,...
Understanding the concepts of physical dependence,...
01:26Psychosis: Goals of Pharmacotherapy
Antipsychotic drugs are a crucial treatment method for acute and chronic psychoses, bipolar illness, and behavioral disorders. The selection of these drugs depends on several factors, including the state of the disease, clinical judgment, possible drug interactions, and the patient's sensitivity to adverse effects. In immediate scenarios, such as delirium and dementia, short-term treatment with low doses of high-potency typical or atypical agents can effectively manage symptom exacerbation. For...
01:29Psychological and Sociocultural Causes of Schizophrenia
Schizophrenia, a complex psychiatric disorder, has been historically misunderstood. Early psychological theories attributed its origins to childhood trauma and unresponsive parenting. However, contemporary research largely rejects these notions, favoring the vulnerability-stress hypothesis. This model proposes that individuals with a genetic predisposition to schizophrenia may develop the disorder following exposure to significant environmental stressors. Notably, studies on high-risk...
01:27Psychosis: Pathophysiology of Schizophrenia and Other Psychotic Disorders
Schizophrenia is a neurodevelopmental disorder whose origins are rooted in complex genetic components. Despite our burgeoning understanding, the pathophysiology of this disorder remains incompletely deciphered.
Researchers have identified genetic factors that increase susceptibility to schizophrenia, underscoring the intricate interplay between genetics and environment in disease development. At the core of schizophrenia's pathophysiology is excessive dopaminergic neurotransmission within the...
Researchers have identified genetic factors that increase susceptibility to schizophrenia, underscoring the intricate interplay between genetics and environment in disease development. At the core of schizophrenia's pathophysiology is excessive dopaminergic neurotransmission within the...